11-2884966-ACCGCGACCGGAGCCGCGACCGGAG-ACCGCGACCGGAG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001122630.2(CDKN1C):​c.479_490delCTCCGGTCGCGG​(p.Ala160_Ala163del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.23 in 980,206 control chromosomes in the GnomAD database, including 29,470 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A160A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.21 ( 3243 hom., cov: 25)
Exomes 𝑓: 0.23 ( 26227 hom. )

Consequence

CDKN1C
NM_001122630.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.593

Publications

8 publications found
Variant links:
Genes affected
CDKN1C (HGNC:1786): (cyclin dependent kinase inhibitor 1C) This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
CDKN1C Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • IMAGe syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, G2P, Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Beckwith-Wiedemann syndrome due to CDKN1C mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intrauterine growth restriction-short stature-early adult-onset diabetes syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Silver-Russell syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 11-2884966-ACCGCGACCGGAG-A is Benign according to our data. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2884966-ACCGCGACCGGAG-A is described in CliVar as Benign/Likely_benign. Clinvar id is 193042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.27 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1CNM_001122630.2 linkc.479_490delCTCCGGTCGCGG p.Ala160_Ala163del disruptive_inframe_deletion Exon 2 of 4 ENST00000440480.8 NP_001116102.1 P49918-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1CENST00000440480.8 linkc.479_490delCTCCGGTCGCGG p.Ala160_Ala163del disruptive_inframe_deletion Exon 2 of 4 1 NM_001122630.2 ENSP00000411257.2 P49918-2

Frequencies

GnomAD3 genomes
AF:
0.206
AC:
28094
AN:
136298
Hom.:
3242
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.0889
Gnomad AMI
AF:
0.201
Gnomad AMR
AF:
0.224
Gnomad ASJ
AF:
0.309
Gnomad EAS
AF:
0.104
Gnomad SAS
AF:
0.189
Gnomad FIN
AF:
0.178
Gnomad MID
AF:
0.271
Gnomad NFE
AF:
0.273
Gnomad OTH
AF:
0.235
GnomAD2 exomes
AF:
0.282
AC:
62
AN:
220
AF XY:
0.333
show subpopulations
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.292
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.234
AC:
197281
AN:
843828
Hom.:
26227
AF XY:
0.236
AC XY:
95074
AN XY:
403256
show subpopulations
African (AFR)
AF:
0.0674
AC:
1204
AN:
17856
American (AMR)
AF:
0.234
AC:
1568
AN:
6704
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
3224
AN:
11040
East Asian (EAS)
AF:
0.0862
AC:
1841
AN:
21348
South Asian (SAS)
AF:
0.172
AC:
2812
AN:
16370
European-Finnish (FIN)
AF:
0.175
AC:
3476
AN:
19850
Middle Eastern (MID)
AF:
0.253
AC:
592
AN:
2344
European-Non Finnish (NFE)
AF:
0.245
AC:
174902
AN:
714110
Other (OTH)
AF:
0.224
AC:
7662
AN:
34206
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
6728
13456
20185
26913
33641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6406
12812
19218
25624
32030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.206
AC:
28081
AN:
136378
Hom.:
3243
Cov.:
25
AF XY:
0.201
AC XY:
13336
AN XY:
66300
show subpopulations
African (AFR)
AF:
0.0888
AC:
3162
AN:
35590
American (AMR)
AF:
0.224
AC:
3188
AN:
14242
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
1020
AN:
3300
East Asian (EAS)
AF:
0.104
AC:
462
AN:
4446
South Asian (SAS)
AF:
0.189
AC:
816
AN:
4326
European-Finnish (FIN)
AF:
0.178
AC:
1433
AN:
8060
Middle Eastern (MID)
AF:
0.270
AC:
66
AN:
244
European-Non Finnish (NFE)
AF:
0.273
AC:
17323
AN:
63434
Other (OTH)
AF:
0.233
AC:
444
AN:
1906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
958
1915
2873
3830
4788
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0616
Hom.:
79
Asia WGS
AF:
0.103
AC:
320
AN:
3080

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 16, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 07, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Beckwith-Wiedemann syndrome Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2019
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 14, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20503313, 8655143) -

Inborn genetic diseases Benign:1
Aug 18, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

CDKN1C-related disorder Benign:1
Sep 19, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.59
Mutation Taster
=198/2
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs565544512; hg19: chr11-2906196; COSMIC: COSV57832997; COSMIC: COSV57832997; API